GLP-1, or glucagon-like peptide 1, plays a crucial role in regulating blood sugar levels by stimulating insulin secretion from pancreatic beta cells. In recent years, GLP-1 receptor agonists have emerged as a significant therapeutic option for managing type 2 diabetes mellitus (T2DM) due to their ability to mimic the action of endogenous GLP-1. As with…